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Mitochondria play essential roles in many aspects of
biology, and their dysfunction has been linked to
diverse diseases. Central to mitochondrial function
is oxidative phosphorylation (OXPHOS), accom-
plished by respiratory chain complexes (RCCs) en-
coded by nuclear and mitochondrial genomes. How
RCC biogenesis is regulated in metazoans is poorly
understood. Here we show that Parkinson’s disease
(PD)-associated genes PINK1 and Parkin direct
localized translation of certain nuclear-encoded
RCC (nRCC) mRNAs. Translationally repressed
nRCC mRNAs are localized in a PINK1/Tom20-
dependent manner to mitochondrial outer mem-
brane, where they are derepressed and activated
by PINK1/Parkin through displacement of transla-
tion repressors, including Pumilio and Glorund/
hnRNP-F, a Parkin substrate, and enhanced binding
of activators such as eIF4G. Inhibiting the translation
repressors rescued nRCC mRNA translation and
neuromuscular-degeneration phenotypes of PINK1
mutant, whereas inhibiting eIF4G had opposite ef-
fects. Our results reveal previously unknown func-
tions of PINK1/Parkin in RNA metabolism and sug-
gest new approaches to mitochondrial restoration
and disease intervention.
INTRODUCTION
Mitochondria (mito) exert essential cellular functions, from bio-
energetics and intermediary metabolism to ion homeostasis
and apoptosis. Mito integrity is particularly important for neuro-
muscular (NM) tissues with high energy demand (Chan, 2006;
Wallace, 2005). Other aspects of mito physiology are also impor-
tant for these tissues. In neurons, mito help buffer Ca2+ influxes
elicited by neuronal activity (Mattson et al., 2008; Saxton and
Hollenbeck, 2012). It is thus not surprising that mito dysfunction
has been linked to various neurological disorders (Chan, 2006;CSchon and Przedborski, 2011; Wallace, 2005). The cause of
mito dysfunction in most diseases, however, remains largely
undefined.
OXPHOS is arguably the most fundamental mito function car-
ried out by five RCCs whose subunits are dually encoded by the
nuclear and mito genomes. The biogenesis and maintenance of
RCCs require regulated expression of nRCC and mito-encoded
RCC (mtRCC) genes. How this process is coordinated is not
well understood. Subcellular targeting and local translation of
mRNAs offers an effective mechanism to achieve spatially
restricted protein synthesis (Balagopal and Parker, 2009; Besse
and Ephrussi, 2008), making it highly pertinent to processes like
RCC biogenesis. In yeast, mtRCC mRNAs are targeted close to
the mito inner membrane (MIM) (McMullin and Fox, 1993),
whereas certain nRCC mRNAs are recruited to the vicinity of
mito outer membrane (MOM) (Kellems et al., 1975). Localized
translation of nRCC and mtRCC mRNAs presumably ensures
cotranslational import and assembly of subunits into multimeric
RCCs. Whether mito-resident regulatory factors are required
for this process and the in vivo significance of this process in
metazoans are largely unknown.
PD is an age-dependent degenerative condition caused pri-
marily by dopaminergic neuron (DN) deficits. Mito dysfunction
and OXPHOS impairment in particular have been profoundly
implicated in PD pathogenesis (Henchcliffe and Beal, 2008).
Strong genetic evidence supporting a mito etiology of PD
came from the identification of a familial PD (FPD) gene PINK1
(Pten-induced kinase 1) encoding amito-targeted Ser/Thr kinase
(Valente et al., 2004). Genetic studies in Drosophila first estab-
lished that PINK1 and another FPD gene product, Parkin, an
E3 ubiquitin ligase, act in a common pathway to maintain mito
function (Clark et al., 2006; Park et al., 2006; Yang et al., 2006).
Recent studies have emphasized roles of PINK1 and Parkin in
mitophagy (Narendra et al., 2010).
We previously observed OXPHOS impairment in Drosophila
PINK1model (Liu et al., 2011). Here we investigated the underly-
ing molecular cause. Our results reveal a previously unknown
mechanism of PINK1 action in regulating localized translation
of select nRCC mRNAs, whereby PINK1 acts as a mito-resident
regulatory factor to promote the MOM-targeting of nRCC
mRNAs via the translocase of outer membrane (TOM) complex.
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Figure 1. PINK1 Regulates mRNA Localiza-
tion and Protein Expression of Select nRCC
Genes in Drosophila
(A) RT-PCR and western blot (WB) analyses of
RCC mRNAs and proteins in PINK1 thoracic
muscle. mRNAs or proteins prepared from total,
cyto, or mito fractions were used. Mito-bound
nRCC mRNA levels were normalized with Porin
protein level, total and cyto mRNA levels with
rps49, and protein levels with actin (n = 3 experi-
ments). Since the expression of the mtRCC gene
C-IV s1 is not altered by PINK1, it is used later to
normalize RNA and protein levels of nRCC genes.
(B) RT-PCR and WB of RCC mRNAs and proteins
in PINK1 head tissues. Experiments were done as
in (A) (n = 3 experiments).
(C) qRT-PCR of RCC mRNAs in total and subcel-
lular fractions from PINK1 muscle tissues (n = 3–4
experiments).
(D and E) RNA FISH of nRCC mRNAs and control
marf mRNA in wild-type muscle. Mito and nuclei
were labeled with mito-GFP and TOPRO3,
respectively. Arrows, RNA particles colocalizing
(white) or not colocalizing (red) with mito. Scale
bar, 25 mm.Bar graph in (E) shows quantification of
RNA signals colocalizing with mito (150 signals
from three individual animals).
Error bar, SEM; *p < 0.05 in Student’s t tests. See
also Figure S1.the cytosol. Upon recruitment to MOM, however, they are trans-
lationally derepressed and activated by PINK1 and Parkin. The
in vivo significance of this process is supported by the pheno-
typic rescue of PINK1mutant after inhibiting the translational re-
pressors bound to nRCC mRNAs, including Pumillio (Pum),
GW182, and Glorund (Glo), the fly homolog of hnRNP-F/H.
We also show that PINK1 and Parkin cooperate to promote96 Cell Metabolism 21, 95–108, January 6, 2015 ª2015 Elsevier Inc.hnRNP-F/Glo ubiquitination, thus directly
linking the PINK1/Parkin pathway to
mRNA metabolism and translational con-
trol of OXPHOS.
RESULTS
PINK1 Regulates the mRNA
Localization and Protein
Abundance of Certain nRCC Genes
in Drosophila
To understand the OXPHOS defects in
PINK1 mutant, we examined the expres-
sion of RCC proteins in NM tissues of
control and PINK1B9 mutant flies. Ten
RCC (7 nRCC and 3 mtRCC) proteins
were chosen for analysis. Levels of four
nRCC proteins, including the 30 kDa sub-
unit of complex-I (C-I 30), OSCP subunit
of C-V, core protein 2 of complex-III,
and ND75 subunit of complex-I (Figures
1A and 1B; data not shown), were
reduced, whereas other nRCC proteins
tested were unaltered in PINK1 mutant(Figure S1A). Levels of threemtRCCproteins tested, cytochrome
c oxidase subunit I (C-IV-s1) (Figures 1A and 1B), ATP synthase
subunit 6, and cytochrome b (Figure S1A), were not changed.
The levels of several nuclear-encoded mito proteins, e.g., Porin
(VDAC) and MCU, were also unaffected (Figure S1A). PINK1 ap-
pears to specifically regulate the expression of select nRCC
proteins.
Figure 2. PINK1 Regulates mRNA Localization and Protein Expression of Select nRCC Genes in Mammalian Cells
(A) Semiquantitative RT-PCR of mito-bound nRCC mRNAs in HEK293 cells with hPINK1 knocked down or transfected with PINK1-WT or PINK1-G309D.
Knockdown efficiency is shown in Figure S2D. Bar graph shows normalized mito-bound nRCC mRNA levels (n = 3 experiments).
(B) qRT-PCR of RCC mRNAs in total and subcellular fractions of HEK293 cells transfected with PINK1-WT or PINK1-G309D (n = 3 experiments).
(C) WB of RCC proteins in HEK293 cells transfected with PINK1-WT or PINK1-G309D.
(D) Mitochondrial morphology in fibroblasts or iDNs from control subject (WT) and PINK1(G309D) patient.
(E) Quantification of mito size in the periphery of fibroblasts and iDNs (left) and signal intensity ratios of mito-GFP versus Tuj-1 in iDN neurites (right). For each
sample at least four cells were analyzed (*p < 0.05).
(F–H) ATP level (F) and nRCC mRNA (G) and protein (H) expression in control (WT) and PINK1(G309D) fibroblasts and iDNs (*p < 0.05, n = 4).
See also Figure S2.We next examined the mechanisms underlying the selective
reduction of nRCC proteins in PINK1 mutant. Semiquantitative
RT-PCR and quantitative real-time RT-PCR (qRT-PCR) revealed
that total mRNA levels for the affected proteins were largely un-
affected (Figures 1A–1C). To test whether localized translation
might be involved, we analyzed nRCCmRNA distribution in sub-
cellular fractions. In the cytosolic (cyto) fraction, nRCC mRNA
levels were comparable between control and mutant (Figures
1A–1C). Intriguingly, a fraction of the mRNAs for the affected
nRCC subunits were found in Percoll gradient-purified mito (Fig-
ures 1A–1C), the purity of which was verified by the absence of
other membrane structures such as the ER and endosomes (Fig-
ure S1B). RNase A treatment of purifiedmito degraded the nRCC
mRNAs, but notmtRCCRNAs residing in thematrix (Figure S1C),
suggesting that the nRCCmRNAs are MOM bound. Fluorescent
in situ hybridization (FISH) confirmed the mito localization of
select nRCCmRNAs (Figures 1D and 1E; Figure S1D), and trans-
mission EM analysis revealed the association of ribosomes with
muscle MOM, suggesting ongoing translation on MOM (Fig-
ure S1E). Strikingly, correlating with the change of protein levels,Clevels of MOM-bound nRCC mRNAs, but not mtRCC mRNAs,
were significantly reduced in NM tissues of PINK1 mutant (Fig-
ures 1A–1C). In contrast, in the intestine, which was phenotypi-
cally normal in PINK1mutant, themRNA localization, and protein
expression of those nRCC genes were unaltered (Figure S1F).
PINK1 thus regulates the mRNA localization and protein expres-
sion of select nRCC genes in a tissue-specific manner. Due
to the importance of C-I to PD in general (Schapira, 2010), and
C-I 30 to PINK1 function in particular (Wu et al., 2013), we
focused on C-I 30 mRNA in later analyses.
PINK1 Regulates the mRNA Localization and Protein
Expression of Select nRCC Genes in Human DNs
We next tested possible conservation of PINK1 function in nRCC
mRNA regulation. In HEK293T cells, the nRCC mRNAs homolo-
gous to those regulated by PINK1 in flies were found in highly
purified mito (Figures 2A, 2B, and S2A). Mito localization of
mammalian C-I 30 mRNA was further confirmed using the
MS2-GFP/MS2-bs tagging system (Bertrand et al., 1998) (Fig-
ures S2B and S2C). Moreover, in PINK1 siRNA-treated cells,ell Metabolism 21, 95–108, January 6, 2015 ª2015 Elsevier Inc. 97
Figure 3. Involvement of Pum and TOM/TIM Complex in the MOM Localization and Translation of Select nRCC mRNAs
(A) WB showing the presence of Pum in the mito fraction of Mhc-Gal4 > Pum-WT muscle. C-I 30 serves as mito marker and actin as loading control.
(B) Effects of PINK1 mutation on the MOM recruitment of Pum.
(legend continued on next page)
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levels of MOM-bound nRCCmRNAs were significantly reduced,
whereas mtRCC RNA (C-IV s1) was unaffected (Figures 2A
and S2D). Similar to PINK1 RNAi, expression of pathogenic
PINK1(G309D) (Hoepken et al., 2007) greatly reduced levels of
MOM-bound nRCC mRNAs, but not mtRCC RNA (Figures 2A
and 2B), suggesting that PINK1(G309D) acts in a dominant-
negative manner. Not all nRCC mRNAs or mRNAs for nuclear-
encoded mito proteins were MOM bound (Figures 2A and
S2D). Correlating with the change in abundance of MOM-bound,
but not total, mRNAs of select nRCC genes, their protein levels
were also reduced when PINK1 was inhibited (Figure 2C).
Thus, the function of PINK1 in nRCCmRNA localization and pro-
tein expression is conserved in human cells.
To validate these findings in disease-relevant neurons, we
used induced DNs (iDNs) trans-differentiated from patient skin
fibroblasts (Caiazzo et al., 2011). Expression of DN-related
markers and DN-like transcriptomes were confirmed in iDNs
(Figure S2E–S2G). The functionality of iDNs was validated by
rescue of locomotor deficit in 6-OHDA-lesioned rats upon
transplantation (Figure S2H). Comparison of PINK1(G309D) pa-
tient iDNs with control iDNs revealed disease-specific abnormal
mito distribution andmorphology in neuronal processes (Figures
2D and 2E) and reduced ATP levels (Figure 2F). Importantly,
reduced mito-association of select nRCC mRNAs and reduced
protein levels were observed in patient iDNs (Figures 2G and
2H). Patient fibroblasts, however, did not show significant
change in mito distribution, morphology (Figures 2D and 2E),
ATP production (Figure 2F), or nRCC protein expression (Figures
2G and 2H), indicating that the PINK1(G309D) mutation exerts
DN-specific effects on mito function.
PINK1 Functionally Interactswith Pumand the TOM/TIM
Complex to Regulate the Localization and Translation of
nRCC mRNAs
The tight correlation of levels of select nRCC proteins with their
mRNAs in the mito fraction, but not their mRNAs in the cyto frac-
tion, which constitute the majority of total mRNAs (Figure S3A)
and were unchanged in PINK1 mutant (Figure 1C), suggests
that the MOM-bound nRCC mRNAs are translationally active,
whereas those in the cyto are repressed. Indeed, we observed
cytoplasmic ribosomes associated with MOM (Figure S1E) and
detected cytoplasmic translation factors in highly purified mito
from fly tissues or human cells (Figure S3B).Moreover, polysome
analysis of cyto and mito fractions indicated that PINK1-regu-
lated nRCCmRNAs are translationally more engaged in the latter
fraction (Figure S3C), a notion supported by in vitro translation
assays (Figure S3D). Consistently, PINK1-regulated nRCC pro-
teins are present almost exclusively in the mito fraction, whereas
ND42 and Tom20, which are synthesized in the cyto and subse-(C) RT-PCR and WB showing the effect of Pum RNAi on the MOM localization a
(D) qRT-PCR showing the effect of Pum RNAi on RCC mRNA levels in the total a
(E) RT-PCR and WB showing the effects of Pum, Tom40, or Tim8 RNAi on the de
(n = 3 experiments).
(F–H) Effects of Pum, TOM40, or TIM8 RNAi on the wing posture, jumping ability, A
mutation in flight muscle (G) or DNs (H) (n = 3 experiments, 20–25 flies per genoty
25 mm.
(I and J) Effects of Pum-1 RNAi on C-I 30 protein expression (I) and ATP level (J)
Error bar, SEM; *p < 0.05 in Student’s t tests. See also Figure S3.
Cquently imported into mito, are present in both the cyto and mito
fractions (Figure S3E).
To probe the molecular mechanism of translational control of
nRCC mRNAs, we tested the role of the translational repressor
Pum (Quenault et al., 2011). Pum is present in both the cyto
and mito fractions in fly tissues (Figure 3A) and mammalian cells
(Figure S3F). The mito localization of Pum appeared to be regu-
lated by PINK1, as the amount of mito-bound Pum, but not total
Pum, was reduced in PINK1 mutant tissues (Figure 3B) or
PINK1(G309D)-transfected HEK293 cells (Figure S3G). To test
whether the mito localization of Pum depends on its binding to
mRNA, we treated purified mito with RNase A and observed
significantly reduced mito association of Pum (Figure S3H).
Moreover, an RNA binding-deficient form of Pum (Friend et al.,
2012) was compromised in mito localization (Figure S3I), sug-
gesting thatPummaybe recruited toMOMviabinding tomRNAs.
We next tested the role of Pum in nRCC mRNA translation.
Pum RNAi moderately increased mito-bound nRCC mRNAs
and their protein levels in fly muscle tissues (Figures 3C, 3D,
and S3J). Similar effect was observed in HEK293 cells (Fig-
ure S3K). Importantly, Pum RNAi effectively restored levels of
MOM-bound nRCC mRNAs and their proteins in PINK1 RNAi
(Figure 3E) or PINK1 mutant (Figure S3L) muscle tissues.
Since all nRCC proteins require passage through the TOM/
TIM complex to enter mito, we asked whether the MOM-target-
ing and translation of nRCC mRNAs is linked to nascent nRCC
protein import. For this purpose, we knocked down components
of the TOM/TIM complexes. Inhibition of Tom40 or Tim8 strongly
exacerbated PINK1 mutant effects on the MOM-targeting and
translation of nRCC mRNAs (Figures 3E and S3L). Independent
RNAi lines for each gene produced similar effects (Figure S3N).
The MOM-targeting and translation of nRCC mRNAs thus ap-
pears to be linked to protein import during RCC biogenesis.
PINK1 has been shown to regulate mito fission/fusion dy-
namics (Yang et al., 2008) andmotility (Liu et al., 2012). However,
loss- or gain-of-function of genes involved in fission/fusion
(Drp1, Marf) or motility (Miro) had no obvious effect on the levels
of MOM-bound nRCC mRNAs, although for some unknown
reason the protein levels of C-V (OSCP) and C-I 30 were reduced
in Drp1-DN or Miro overexpression (OE) conditions (Figure S3O).
Thus, defects in mito dynamics or motility cannot explain the ef-
fect of PINK1 on select nRCC mRNA localization or translation,
and PINK1 appears to play a specific role in this process.
Altered Pum and TOM/TIM Activities Modulate PINK1
Mutant Effects on NM Tissue Function and Integrity in
Drosophila
We next assessed the effects of Pum and Tom/Tim on PINK1
function at the organismal level. While Pum RNAi had little effectnd protein expression of nRCC mRNAs (n = 3 experiments).
nd subcellular fractions (n = 3–4 experiments).
fective MOM localization and translation of nRCC mRNAs in PINK1 RNAi flies
TP level, and DN loss (F), and on the mito aggregation defect caused by PINK1
pe per experiment; for DN counting, 7–8 animals were assayed). Scale bar (G),
in control and PINK1(G309D) iDNs (n = 3 experiments).
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on NM tissue function or integrity on its own, it effectively
rescued the wing posture, jumping ability, ATP level, and DN sur-
vival defects of PINK1B9 mutant (Figure 3F) or PINK1 RNAi flies
(Figure S3M). In addition, Pum RNAi rescued the abnormal
mito morphology caused by PINK1 inactivation (Figures 3G
and 3H). Consistent with Pum performing a conserved function,
a portion of mammalian Pum-1 was localized to mito (Fig-
ure S3F), and Pum-1 RNAi rescued the reduced nRCC protein
expression and ATP production in PINK1(G309D) iDNs (Figures
3I and 3J).
In contrast to the rescuing effect of Pum RNAi, Tim8 or Tom40
RNAi exacerbated PINK1mutant phenotypes in muscle (Figures
3F, 3G, and S3M) and DNs (Figure 3H). Moreover, Tim8 or
Tom40 RNAi, but not Pum RNAi, caused mild mito aggregation
and DN loss (Figures S4A and S4B), emphasizing the importance
of TOM/TIM to DN health. To further probe the function of
the TOM/TIM complex, we inhibited additional components.
RNAi of Tom7 and Tom20, but not Tim10 or Tim13, enhanced
PINK1 mutant phenotypes (Figure S4C). Since the knockdown
efficiencies of the various RNAi transgenes were similar
(Figure S4D), their differential genetic interactions with PINK1
suggest that components of the TOM/TIM complex do not func-
tion equivalently in the PINK1 pathway. We further probed the
genetic epistasis between PINK1 and TOM in gain-of-function
studies. PINK1 mutant phenotypes were specifically rescued
by Tom20 OE (Figure S4E); reciprocally, PINK1 OE rescued
Tom20 RNAi effects (Figure S4F). These results, together with
their mutual enhancement of mutant phenotypes shown later,
suggest that PINK1 and Tom20 may act at the same level,
e.g., by working together in a complex, rather than at different
steps of a linear pathway.
We also examined Pum OE effects. While strong Pum OE
with the muscle-specific Mhc-Gal4 driver was lethal, weak
or medium Pum OE lines produced viable progenies with mus-
cle defects (Figures 4A and S4G). Using the medium Pum OE
line (Pum-m), we found that its phenotypic effects correlated
well with impaired MOM-targeting and translation of nRCC
mRNAs (Figures 4B and 4C). In DNs, abnormal mito aggrega-
tion and neuronal loss (Figure 4D) similar to that seen in PINK1
mutant were observed in TH-Gal4 > Pum-m flies. PINK1 OE
failed to rescue Pum-m OE effects (Figure S4H). This result,
together with the rescue of PINK1 mutant phenotypes by
Pum RNAi (Figure 3), suggests that Pum may act downstream
of PINK1.
PINK1-TOM20 Interaction Promotes the MOM-
Targeting and Translation of nRCC mRNAs
We sought to elucidate the molecular basis of the genetic inter-
actions between TOM and PINK1, especially between Tom20
and PINK1. Tom20 is a key component of the protein import
system that serves as a receptor for precursor proteins contain-
ing mito targeting sequences (MTS). Recently, PINK1 was found
to associate with the TOM complex in depolarized mito in
mammalian cells (Lazarou et al., 2012), although its physiolog-
ical role was unclear. We hypothesized that Tom20 helps an-
chor translating nRCC mRNAs and associated ribosomes/
RNPs to the MOM, presumably through binding to MTS of
nascent nRCC proteins during cotranslational import, and
that PINK1 may facilitate this process. To test this model, we100 Cell Metabolism 21, 95–108, January 6, 2015 ª2015 Elsevier Incanalyzed Tom20 immunoprecipitate (IP) prepared from fly mus-
cle (Figure 4E) and HEK293T cells (Figure 4F). To stabilize
endogenous PINK1, we briefly subjected flies or cultured cells
to mild CCCP treatment (Narendra et al., 2010). We found that
PINK1 and Pum, but not Parkin, associated with Tom20. The
association of PINK1 or Pum with Tom20 was dramatically
reduced by RNase A treatment (Figures 4E and 4F), whereas
Tom20-Tom40 interaction was not affected (Figure 4F). The
RNA dependency of the above interactions prompted us to
test the involvement of nRCC mRNAs. RNA-IP of fly muscle
(Figure S4I) or HEK293 cells (Figure S4J) showed that the levels
of nRCC mRNAs associated with Tom20 were reduced when
PINK1 was inhibited. Supporting a critical role of Tom20-
PINK1 interaction in the localization and translation of nRCC
mRNAs, Tom20 RNAi inhibited the MOM-targeting and transla-
tion of nRCC mRNAs (Figures 4G and 4H). Moreover, Tom20
RNAi enhanced the reduced MOM-targeting and translation of
nRCC mRNAs (Figure 4I), mito aggregation (Figures S4L and
S4M), and muscle degeneration (Figure S4C) effects of PINK1
mutation, whereas Tom20 OE had opposite effects (Figures
S4E and S4K).
RNA-Dependent Association of PINK1 with eIF4G and
Other Components of the Translation Initiation Complex
Wenext probed themechanism bywhich PINK1 regulates nRCC
mRNA translation. We found that PINK1 associated with mRNA
50 cap structure, as detected by m7-GTP sepharose chromatog-
raphy (Figure 5A). Importantly, the G309D mutation impaired
such association (Figure 5B). The association of PINK1 with
m7-GTP sepharose was RNA dependent, whereas m7-GTP se-
pharose binding by eIF4E, a translation initiation complex (TIC)
component that directly binds to 50 cap, was RNA independent
(Figure 5A), suggesting that PINK1 may associate with mRNA
50 cap indirectly through the TIC. Indeed, endogenous PINK1
exhibited RNA-dependent associations with TIC components
eIF4A and eIF4G, which occurred in the mito and cyto fractions
(Figure 5C). It is worth pointing out that the association between
PINK1 and eIF4G was not eliminated by RNase A treatment (Fig-
ure 5C), and PINK1 did not associate with eIF4E, suggesting
certain degree of specificity and directness of PINK1-eIF4G
interaction. Human genetics studies recently implicated eIF4G
as a candidate FPD gene (Chartier-Harlin et al., 2011). We tested
whether the PINK1-eIF4G association might be altered in dis-
ease condition and found that the G309D mutation attenuated
PINK1-eIF4G interaction (Figure 5D). PINK1 also associated
RNA-dependently with polyA binding protein (PABP), a protein
known to interact with the TIC to promote translation (Figure 5E).
Together, these data support a role of PINK1 in promoting trans-
lation through RNA-dependent and possibly RNA-independent
associations with the TIC.
To further demonstrate the role of PINK1 in regulating the
translation of mito-bound nRCC mRNAs, we made a transla-
tional reporter in which the synthesis of a luciferase-C-I 30 fusion
protein is under the control of the 50 and 30 UTRs ofC-I 30mRNA.
Combining in vitro transcribed reporter mRNA with purified mito
from PINK1-WT transfected HEK293T cells led to stimulated
translation of the reporter (Figure S5A). Using the same assay,
we found that purified mito from PINK1 or parkin mutant fly tis-
sues or PINK1/ knockout mice tissues translated the reporter.
Figure 4. Effects of Pum Overexpression and a TOM20-PINK1 Complex on the Localization and Translation of nRCC mRNAs
(A) Effects of Pum OE on wing posture, jumping ability, and ATP levels. Weak (Pum-w) and moderate (Pum-m) Tg lines were used (n = 3 experiments, 20–25 flies
per genotype per experiment).
(B) RT-PCR and WB showing the effect of Pum-m OE on the MOM localization and translation of nRCC mRNAs (n = 3 experiments).
(C) qRT-PCR showing the effect of Pum-m OE on RCC mRNA levels in the total and subcellular fractions (n = 3 experiments).
(D) Effects of Pum-w and Pum-m OE on mito morphology and survival of DNs (n = 7–8 flies). Scale bar, 5 mm.
(E) RNA-dependent interaction of Tom20 with PINK1 or Pum as detected by co-IP using fly muscle extracts.
(F) Tom20-interacting proteins as detected by co-IP. Extracts made from CCCP-treated HEK293 cells were mock treated or treated with RNase A before IP.
*, Pum-1 signal.
(G) RT-PCR and WB showing the effect of Tom20 RNAi on the MOM localization and translation of nRCC mRNAs in fly muscle (n = 3 experiments).
(H) qRT-PCR showing the effect of Tom20 RNAi on RCC mRNA levels in the total and subcellular fractions (n = 3–4 experiments).
(I) RT-PCR and WB showing the effect of Tom20 RNAi on the defective localization and translation of nRCC mRNAs in PINK1 mutant (n = 3 experiments).
Error bar, SEM; *p < 0.05 in Student’s t tests. See also Figure S4.mRNA at a lower efficiency than WT mito (Figures S5B–S5D).
Collectively, these data support a role of PINK1 in stimulating
the translation of MOM-bound C-I 30 mRNA.
PINK1 Binds to nRCC mRNAs
We sought to elucidate the molecular basis of the RNA depen-
dency of PINK1 association with TIC. RNA-IP analysis revealed
PINK1 association with nRCC mRNAs (Figure 5F). To testCewhether PINK1 directly binds mRNAs, we performed crosslink-
ing and immunoprecipitation (CLIP) assays (Ule et al., 2005).
Endogenous PINK1 directly bound to C-I 30 and C-Va mRNAs
but not Mfn2 mRNA (Figure 5G). Moreover, compared to
PINK1-WT, PINK1(G309D) bound to C-I 30 mRNA poorly (Fig-
ure 5H), supporting the importance of nRCC mRNA-binding to
PINK1 function. CLIP assays performed onmito fraction showed
that PINK1 binds to MOM-localized C-I 30 mRNA (Figure 5I).ll Metabolism 21, 95–108, January 6, 2015 ª2015 Elsevier Inc. 101
Figure 5. PINK1 Binds to nRCC mRNAs and RNA-Dependently Associates with the TIC
(A and B) m7-GTP sepharose binding showing RNA-dependent association of endogenous PINK1 (control sample) and exogenous PINK1 (Flag-PINK1) with the
TIC (A) and compromised binding of PINK1(G309D) with the TIC (B). eIF4E exhibits RNA-independent m7-GTP binding. Bar graphs show data quantification (n = 3
experiments).
(C) RNA-dependent associations between PINK1 and TIC components in the cyto and mito fractions in co-IP assays.
(D) Compromised association between PINK1-G309D and eIF4G.
(E) RNA-dependent association of endogenous PINK1 with PABP.
(F) RNA-IP showing PINK1 binding to nRCC mRNAs, but not Mfn2 mRNA, in HEK293 cells.
(G) Direct binding of PINK1 to nRCC mRNAs, but not Mfn2 mRNA, in CLIP assays.
(H) Reduced C-I 30 mRNA binding by PINK1-G309D compared to PINK1-WT in CLIP assays.
(I) PINK1 binding to C-I 30 mRNA in both the mito and cyto fractions in CLIP assays.
(J and K) CLIP assays showing competition between PINK1 and Pum-1 in binding to C-I 30mRNA in HEK293 cells transfected with PINK1-WT or PINK1-G309D
(J) or with PINK1 shRNA (K).
See also Figure S5.Pum also exhibited C-I 30 mRNA-binding activity in CLIP as-
says (Figure 5J). In HEK293 cells transfected with PINK1-WT,
mRNA binding by Pum was significantly weakened. In contrast,
nRCC mRNA binding by Pum was enhanced in PINK1(G309D)
transfected cells or PINK1 RNAi cells (Figures 5J and 5K).
These data suggest that PINK1 negatively impacts the nRCC
mRNA-binding activity of Pum. We tested whether this effect
might be mediated by a PINK1/Pum physical interaction. Our
repeated co-IP assays were unable to detect such interaction
(Figure S5E).
PINK1 Promotes Translational Derepression and
Activation of nRCC mRNAs on MOM
Data presented earlier suggest that the MOM-localized nRCC
mRNAs are translationally repressed in the cyto before reaching102 Cell Metabolism 21, 95–108, January 6, 2015 ª2015 Elsevier IncMOM, where they are reactivated by PINK1. To dissect the
molecular mechanism, we generated a construct expressing
C-I 30 mRNA tagged with MS2 binding sites, allowing purifica-
tion of C-I 30 RNPs using GST-MS2. To specifically monitor
events occurring on MOM-bound C-I 30 mRNAs, we used mito
for RNP purification. Analysis of mito C-I 30 RNPs purified from
PINK1-WT or PINK1-G309D transfected cells showed that
PINK1-WT increased the association of eIF4G and PABP with
C-I 30 mRNA (Figure 6A). Intriguingly, a number of translational
repressors, including Dcp1, POP2, Pum-1, hnRNP-F, and
hnRNP-H, were enriched in the C-I 30 RNPs purified from
PINK1-G309D transfected cells (Figure 6A). In the case of
hnRNP-F, we observed a modified form in PINK1-WT trans-
fected cells. These results suggest that PINK1 may translation-
ally derepress nRCC mRNAs on MOM by displacing and/or.
modifying translation repressors and further stimulate translation
by promoting activator association.
We next tested the in vivo relevance of the above findings. The
fly homologs of hnRNP-F/H, known as Glo (Kalifa et al., 2006),
and Dcp1 were found to associate with C-I 30 mRNA in muscle
tissues (Figure 6B). Moreover, in PINK1 mutant more C-I 30
mRNA was bound by Glo and Dcp1 in the mito fraction (Fig-
ure 6C). Binding of repressors to MOM-bound C-I 30 mRNA
was also observed in HEK293 cells (Figure S6A), and increased
repressor binding to nRCC mRNAs was found in PINK1/
mouse midbrain tissues (Figure S6B). Considering that Dcp1 is
a core component of P-bodies (Franks and Lykke-Andersen,
2008), cytoplasmic foci involved inmRNA turnover or repression,
we tested association of other P-body components with C-I 30
mRNA. GW182, a conserved key component of P-body, also
bound toC-I 30mRNA (Figures 6B and 6C), andGW182-positive
foci were found residing in the immediate vicinity ofmito inPINK1
mutant but not wild-type muscle tissues (Figure 6D), suggesting
that nRCC mRNAs might be targeted to P-bodies in PINK1
mutant condition. We further tested the functional relationships
between PINK1 and the translational repressors. Knockdown
of the translation repressors effectively rescued PINK1 loss-of-
function phenotypes, whereas eIF4G knockdown had opposite
effect (Figures 6E–6J). The phenotypic effects of these genetic
interactions correlated well with effects on C-I 30 protein expres-
sion (Figure S6C). Thus, both the positive and negative regula-
tors associated with C-I 30 mRNA are important effectors in
the PINK1 pathway of nRCC mRNA regulation.
Parkin Cooperates with PINK1 to Promote hnRNP-F/Glo
Ubiquitination and nRCC mRNA Translation
Parkin was previously shown to act downstream of PINK1 (Clark
et al., 2006; Park et al., 2006; Yang et al., 2006). We tested the
role of Parkin in translational control of nRCC mRNAs. Parkin
associated with Pum-1 in HEK293 cells (Figure 7A). This associ-
ation raised the possibility that Parkin may mediate the effect of
PINK1 in recruiting Pum to mito. Contrary to this expectation,
mito-bound Pum was increased in parkin mutant (Figure S7A),
suggesting that not only is Parkin not required for theMOM local-
ization of Pum, it may act at a later step to displace Pum from
MOM-localized nRCCmRNAs to relieve translational repression.
Supporting a role for Parkin in translational regulation, we found
that transfected (Figure 7B) and endogenous Parkin (Figure 7C)
associated with 50 cap in an RNA-dependent fashion, that path-
ogenic mutations disrupted this association (Figure 7D), that
Parkin associated with TIC component PABP (Figure 7E), and
that Parkin stimulated the translation of the C-I 30 reporter (Fig-
ure S5D). As in PINK1 mutant, the levels of MOM-bound nRCC
mRNAs and their proteins were reduced in parkin mutant (Fig-
ures 7F and 7G). However, unlike inPINK1, parkinmutant pheno-
types were not rescued by Pum RNAi (Figure S7B). Moreover,
unlike PINK1-OE, Parkin OE was able to rescue Pum OE effects
on nRCC mRNA translation and tissue integrity (Figures 7H and
S7C), suggesting that Parkin may function downstream of Pum.
We next searched for potential target(s) of Parkin mediating its
effect on nRCCmRNA translation. A number of observations led
us to focus on Glo. First, Glo RNAi effectively rescued PINK1
mutant (Figures 6E–6J), whereas Glo OE had opposite effect
(Figures S7D and S7E). Second, in PINK1 and parkin mutants,Cemore nRCCmRNAs bound to Glo in the mito fraction (Figure 7I).
Third, Glo physically associated with Parkin in fly tissues (Fig-
ure S7F). Fourth, we observed modification of hnRNP-F by
PINK1-WT in C-I 30 RNP (Figure 6A). We tested whether Parkin
might ubiquitinate Glo. A Ub-positive, higher-molecular-weight
species consistent with monoubiquitinated Glo was detected
in Glo-IP prepared fromwild-type but not parkin orPINK1mutant
flies, suggesting that PINK1 and Parkin regulate Glo ubiquitina-
tion (Figure 7J). Interestingly, in PINK1 mutant expressing a
phospho-mimetic, but not a nonphosphorylatable form of Parkin
with the PINK1 phosphorylation site mutated (Shiba-Fukushima
et al., 2014), Glo ubiquitination was restored (Figure S7G),
indicating that PINK1 acts through Parkin to regulate Glo ubiqui-
tination. Ubiquitination of hnRNP-F by PINK1/Parkin was also
observed in mammalian cells, in which the WT (Parkin-WT) or
phospho-mimetic (Parkin-S65E), but not E3-dead (Parkin-
C431S) or nonphosphorylatable (Parkin-S65A) forms of Parkin,
induced hnRNP-F monoubiquitination (Figure 7K). These data
support that Glo/hnRNP-F is a direct substrate mediating the
effect of PINK1/Parkin on nRCC mRNA translation. Glo or
hnRNP-F protein level was not obviously changed by altered
PINK1 or Parkin activities (Figures 7I–7K), consistent with mono-
ubiquitination generally not affecting protein stability. We hy-
pothesize that ubiquitination of Glo alters the structure of the
repressor complexes and their binding to nRCC mRNAs. Sup-
porting this notion, repressor binding to C-I 30 mRNA was
increased in parkin mutant, but reduced in PINK1 mutant upon
Parkin OE (Figures S7H and S7I).
DISCUSSION
We report a role of the PINK1/Parkin pathway in regulating the
MOM-targeting and translation of select nRCC mRNAs. Since
similar effects were observed in vivo in flies and in mammalian
cells, including human iDNs, this newly identified function is likely
to be fundamental to PINK1/Parkin biology and PD pathogen-
esis. Combined with the synthesis of mtRCC proteins near the
MIM, localized translation of nRCC mRNAs and cotranslational
protein import on MOM allow efficient assembly of the multisu-
bunit RCCs. As the PINK1/Parkin-regulated nRCC proteins and
the mtRCC proteins are extremely hydrophobic, their coupled
synthesis and assembly onmitomembrane avoids potential mis-
folding or aggregation in the cytosol or matrix. Defects in this
process could contribute to the mito etiology of PD and possibly
other age-related disorders. Our results further suggest that
pharmacological agents targeting the key players involved in
localized nRCCmRNA translationmay offer rational therapeutics
for PD.
Our results implicate PINK1 in the localization of nRCCmRNAs
to MOM. PINK1 may act in this process through its binding to
nRCC mRNAs and through its interaction with Tom20. Tom20/
TOM may act in the initial recruitment of nRCC mRNA RNPs
from the cytosol toMOM, analogous to the targeting of ER-asso-
ciated mRNAs, stalled ribosomes, and the SRP to the ER.
An alternative, though not mutually exclusive, mechanism of
nRCC mRNA targeting to MOM may involve RNA-binding pro-
teins. Previous studies in yeast implicated Tom20 and a Pum ho-
molog, Puf3p, in directing the mito localization of some nRCC
mRNAs (Eliyahu et al., 2010). We found that the sole Pum in fliesll Metabolism 21, 95–108, January 6, 2015 ª2015 Elsevier Inc. 103
Figure 6. PINK1 Derepresses and Activates the Translation of MOM-Bound nRCC mRNAs
(A) WB of mito C-I 30 mRNA-RNPs purified from HEK293 cells transfected with PINK1-WT or PINK1-G309D. Red arrow: a higher MW species of hnRNP-F.
(B) RNA-IP of wild-type thoracic mito showing association of Glo, Dcp1, and GW182 with C-I 30 mRNA. Rps49 and marf serve as negative controls.
(legend continued on next page)
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is localized to mito in PINK1- and RNA binding-dependent man-
ners. Moreover, Pum inhibition increased, whereas Pum OE
decreased, nRCC mRNA abundance on MOM, arguing against
a positive role of Pum in directing nRCC mRNA localization.
The primary role of Pum in nRCCmRNA regulation in metazoans
is likely translational repression, and its effect on nRCC mRNA
abundance on MOM is likely due to links between mRNA trans-
latability and stability (Balagopal and Parker, 2009; Besse and
Ephrussi, 2008). Thus, although the process of nRCC mRNA
localization to MOM is conserved from yeast to humans, the un-
derlying mechanisms likely differ between yeast andmetazoans.
Consistently, while PINK1 acts as a key regulator of nRCCmRNA
targeting and translation in flies and mammals, there is no coun-
terpart of PINK1 in yeast.
Our results support direct roles of PINK1/Parkin in transla-
tional control of nRCC mRNAs. Several observations support
this conclusion. First, our CLIP assays showed that PINK1
directly binds to nRCC mRNAs and competes with Pum for
nRCC mRNA binding. Second, PINK1 physically associates
with mRNA 50 cap structures and components of the TIC,
including eIF4A, eIF4G, and PABP, in an RNA-dependent
manner, and at least in the case of eIF4G, RNA-independent
interaction may also occur. PINK1 also positively regulates the
association of eIF4G and PABP to C-I 30 mRNA. Of particular
interest is PINK1’s relationship with eIF4G, mutations in which
have been tentatively linked to autosomal dominant PD. Our
results support that defective translational control may play a
broader role in PD pathogenesis (Lu et al., 2014). Third, our
results indicate that PINK1/Parkin actively participate in the
derepression of nRCC mRNAs by displacing the translational
repressor hnRNP-F/Glo from nRCC mRNAs. The association of
other repressors, such as Pum, Dcp1, GW182, and POP2, with
nRCC mRNA was also affected in PINK1 or parkin mutants,
although the detailed molecular mechanism remains to be eluci-
dated. Given that Dcp1 and GW182 are components of the P-
body (Franks and Lykke-Andersen, 2008), our results suggest
that P-bodies and possibly stress granules, related cytoplasmic
structures in the turnover or storage of translationally stalled
mRNAs (Balagopal and Parker, 2009), may be intimately linked
to PINK1/Parkin pathogenesis. Fourth, PINK1 and Parkin pro-
mote monoubiquitination of hnRNP-F/Glo to displace hnRNP-
F/Glo and other repressors from nRCC mRNAs. hnRNPs func-
tion in distinct RNP complexes to control broad aspects of
RNA physiology. Glo was identified as a protein binding to nanos
mRNA (Kalifa et al., 2006), and it may repress translation at
multiple steps (Andrews et al., 2011). A role for Glo in regulating
translation at the initiation and postinitiation steps would
conform to the proposed roles of PINK1/Parkin in a multistep
regulation of localized nRCC mRNA translation. Although
PINK1 can also interact with the TOM complex, it is unlikely
that the effect of PINK1/Parkin on mRNA translation is mediated(C) RNA-IP showing increased binding of translation repressors to C-I 30 mRNA
(D) Immunofluorescence staining showing increased GW182 localization to swol
(E–G) Effects of translation repressor and eIF4GRNAi onwing posture (E), ATP leve
the top graphs (n = 3 experiments, 20–25 flies per genotype per experiment).
(H–J) Effects of translation repressor and eIF4G RNAi on muscle mito morphology
PINK1 mutant (n = 7–8 flies tested). Scale bar (H), 25 mm; (I), 5 mm.
Error bar, SEM; *p < 0.05 in Student’s t tests. See also Figure S6.
Ceby TOM, since the interaction between PINK1 and TOM is tran-
sient and weaker than the interaction between PINK1 and the
translation machinery, and a direct role for TOM in mRNA trans-
lation is not known. Instead, our data support a direct role of
PINK1/Parkin in translational control.
Our findings broaden the in vivo function of the PINK1/Parkin
pathway in mito regulation. Recent studies have highlighted
the roles of PINK1 and Parkin in mitophagy. Mitophagy and
nRCC mRNA regulation may represent distinct stages of mito
quality control (MQC) by PINK1/Parkin. Being highly active in
metabolism, mito inevitably accumulate oxidative damages to
constituents such as the RCCs during their lifetime. PINK1/Par-
kin may help repair mildly damaged mito, e.g., via localized
translation of nRCC mRNAs to boost OXPHOS. As for severely
damaged mito, PINK1/Parkin may segregate them from healthy
mito, transport them to appropriate cellular locations, and target
them for removal. It will be interesting to test whether and how
these different phases of MQC are connected.
One important implication of this study is that OXPHOS, a
seemingly constitutive and housekeeping function, is tightly
controlled at the level of nRCCmRNA localization and translation
in metazoan NM tissues. It is likely that this process is dynami-
cally regulated under stress, aging, or disease conditions.
Another important implication of this study is that defective
translational control plays broader and multifaceted roles
in neurodegenerative disease. Previous studies implicated
excessive protein synthesis in the pathogenesis of dominantly
inherited neurodegeneration such as LRRK2-associated PD
(Gehrke et al., 2010; Imai et al., 2008), whereas the current study
implicates reduced synthesis of nRCC proteins in PINK1/Parkin-
associated recessive PD.Whether these diseases are caused by
converging pathogenic pathways and how defects in translation,
a supposedly ubiquitous cellular process, lead to cell type-selec-
tive degeneration are important questions for future studies.
EXPERIMENTAL PROCEDURES
Drosophila Genetics
Fly culture and crosses were performed according to standard procedures
and raised at indicated temperatures. The UAS-Tom20, UAS-Tom40, and
UAS-Tom70 transgenic flies were generated by BestGene Inc. Other fly stocks
were obtained from VDRC or Bloomington Drosophila stock centers or from
other investigators.
RT-PCR, qRT-PCR, CLIPAssays, andPurification ofMito-Associated
mRNAs
For RT-PCR analysis, total RNAs were extracted from cell cultures, fly
tissues, or adult mouse midbrain (P27) using an RNeasy Mini Kit, and one-
step RT-PCR was performed using an RT-PCR kit. For qRT-PCR analysis,
purified RNA were mixed with primers and Maxima SYBR Green/ROX
qPCR Master Mix (Thermo Scientific), and PCR products were detected
by StepOnePlus Real-Time PCR system (Applied Biosystems). CLIP assay
was performed under conditions modified from a published methodin PINK1 mutant.
len mito in PINK1 mutant muscle. Scale bar, 25 mm.
l (F), and jumping activity (G) ofPINK1mutant. RNAi alone effects are shown on
inMhc > PINK1-RNAi flies (H) and on DNmito morphology (I) and survival (J) in
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Figure 7. Parkin Cooperates with PINK1 to Promote Glo/hnRNP-F Ubiquitination and nRCC mRNA Translation
(A) Association of endogenous (left) and exogenous (right) Parkin with Pum-1 in co-IP assays.
(B and C) m7-GTP sepharose binding showing RNA-dependent association of myc-Parkin (B) and endogenous Parkin (C) with TIC.
(D) m7-GTP sepharose binding showing impaired association of Parkin (V56E,C212Y) with the TIC.
(E) Association of endogenous Parkin with exogenous PABP in co-IP assays.
(F) RT-PCR and WB showing the effects of parkin mutation on the MOM-targeting and translation of nRCC mRNAs (n = 3 experiments).
(G) qRT-PCR showing the effect of parkin mutation on RCC mRNA levels in the total and subcellular fractions (n = 3 experiments).
(H) RT-PCR and WB showing effects of Parkin or PINK1 OE on the defective MOM-targeting and translation of nRCC mRNAs caused by Pum-m OE (n = 3
experiments).
(I) RNA-IP showing the effect of parkin mutation on C-I 30 mRNA binding by Glo.
(J) Effect of PINK1 and parkinmutations on Glo ubiquitination in fly muscle. Glo IP from control or mutant tissues was probed with anti-Ub. Red arrow, Glo; green
arrow, Ub-Glo.
(K) Effects of WT and mutant forms of hParkin on hnRNP-F ubiquitination. HeLa cells transfected with the indicated constructs were subjected to hnRNP-F IP,
followed by WB. *, Ub-hnRNP-F. Left two lanes of the top panel are from a different gel and used to show that the band below Ub-hnRNP-F is nonspecific.
Error bar, SEM; *p < 0.05 in Student’s t tests. See also Figure S7.(Ule et al., 2005). Intact mito from in vitro cell cultures, fly heads, fly thoraces,
fly intestinal tissues, and mouse midbrain (P7) tissues were purified as
described previously (Kristian et al., 2006), and mito-associated mRNAs
were extracted as described above.106 Cell Metabolism 21, 95–108, January 6, 2015 ª2015 Elsevier IncImmunohistochemistry, RNA FISH, and TEM analysis
Immunohistochemical analyses of mito morphology of adult fly brains and
muscle tissues were essentially done as described (Wu et al., 2013). For immu-
nohistochemical analysis of mitochondrial morphology of adult fly brains and.
muscle tissues, male flies at around 5 days of age and raised at 29C were
used. For analysis of DA neuron number in the various genetic backgrounds,
male flies at around 14 days of age and raised at 29C were used. For RNA
FISH in fly muscle, a protocol modified from a previously published method
was used. Digoxigenin-labeled riboprobes for C-I 30, Oscp and Marf, were
generated using a PCR-based method. For TEM analysis, adult male flies at
around 5 days of age and raised at 29C were used. Samples were further
sectioned and prepared for TEM analysis by the Cell Sciences Imaging Facility
of Stanford University School of Medicine.
DNA Cloning, IP, RNP Purification, m7-GTP Sepharose Affinity
Chromatography, Western Blotting, RNAi, and Translational
Reporter Assays
DNA cloning, IP, western blotting, RNAi, and luciferase-based translational
reporter assays were performed essentially as described (Gehrke et al.,
2010). For RNP purification, cells were transfected with MS2-GST, C-I 30-
MS2-bs, and PINK1 constructs. Sixty hours posttransfection, cells were
UV-crosslinked and mito purified, and mito extracts were subjected to
GST pull-down and WB analyses. For IP and m7-GTP sepharose affinity
chromatography, extracts made from HEK293T cells, fly tissues prepared
from 5-day-old flies raised at 29C, or mouse midbrain (P7) tissue were pre-
pared in lysis buffer (50 mM Tris-HCl [pH 7.4], 150 mM NaCl, 5 mM EDTA,
10% glycerol, 1% Triton X-100, 0.5 mM DTT, 60 mM b-glycerolphosphate,
1 mM sodium vanadate, 20 mM NaF, and complete protease inhibitor cock-
tail [Roche]) and subjected to IP using the indicated antibodies, or pull-
down using m7-GTP sepharose beads at 4C for 4 hr. For WB analysis of
fly samples, male flies at around 5 days of age and raised at 29C were
used.
iDN Culture
Fibroblasts were seeded at 50% confluence onto Matrigel-coated wells and
infected with concentrated lentiviral particles expressing human TFs. Lentiviral
particles were mixed with MEF media containing 8 mg/ml polybrene. Twenty-
four hours postinfection the medium was replaced with MEF medium contain-
ing 2 mg/ml doxycycline to activate TF expression. Medium was gradually
changed to N3 medium (DMEM/F-12 medium containing 25 mg/ml insulin,
50 mg/ml transferrin, 30 nM sodium selenite, 20 nM progesterone, 100 nM pu-
trescine, 2 mg/ml doxycycline), and cells were cultured for 2–3 weeks before
immunohistochemical and biochemical analyses.
Behavioral Assays and ATP Measurement
Wing posture, flight, and jumping ability assays on adult flies and measure-
ments of ATP contents in thoracic muscle were performed as described pre-
viously (Wu et al., 2013). For all wing posture assays, male flies at 1 day and
13–15 days old and aged at 29C were used, except for the Mhc-Gal4 >
Pum-m OE flies, which were assayed at day 1 and day 7, as noted in Fig-
ure 4A. For the jumping and flight ability assays, male flies at 3–5 days of
age raised at 29C were used. For each genotype at least three independent
experiments were performed for these assays. For ATP measurement in
mammalian cells, in vitro cultured cells trypsinized from 3.7 cm2 culture
plates were collected and transferred into a new 1.5 ml reaction tube, centri-
fuged at 1,0003 g at 4C, and washed once with ice cold 13 PBS before
ATP measurement.
Animals
Sprague Dawley (SD) rats were received from Taconic and housed and treated
at the Behavioral and Functional Neuroscience Laboratory (BFNL) at Stanford
University according to the approved protocols APLAC-23885 and APLAC-
26373. All TH-EGFPmice were housed at the animal facility at Stanford Univer-
sity and treated according to the approved protocol APLAC-23865. Control
(C57BL/6J #664) and mPINK1 mutants (B6.129S4-Pink1tm1Shn/J #17946)
mice were purchased from Jackson Laboratory and housed at Stanford Uni-
versity according to the APLAC-22400 protocol.
Statistical Analysis
The statistical significance of all data was evaluated by unpaired Student’s
t tests. Error bars represent standard error of the mean (SEM).
See Supplemental Experimental Procedures for additional details.CeSUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and two tables and can be found with this article online at
http://dx.doi.org/10.1016/j.cmet.2014.12.007.
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